Yanna Tang

1.7k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Yanna Tang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yanna Tang has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Yanna Tang's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (3 papers). Yanna Tang is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Colorectal Cancer Treatments and Studies (3 papers). Yanna Tang collaborates with scholars based in China and United States. Yanna Tang's co-authors include Wenfeng Fang, Shaodong Hong, Shiyang Kang, Jianhua Zhan, Yaxiong Zhang, Yan Huang, Li Zhang, Ting Zhou, Xiaobo He and Tao Qin and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Environmental Research.

In The Last Decade

Yanna Tang

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

2015 534 citations Nan Chen, Wenfeng Fang et al. Journal of Thoracic Oncology profile →

Peers

Countries citing papers authored by Yanna Tang

Since Specialization

Citations

This map shows the geographic impact of Yanna Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanna Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanna Tang more than expected).

Fields of papers citing papers by Yanna Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanna Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanna Tang. The network helps show where Yanna Tang may publish in the future.

Co-authorship network of co-authors of Yanna Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanna Tang. A scholar is included among the top collaborators of Yanna Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanna Tang. Yanna Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Element contents changes during the propagule development of two Sonneratia species 2025 ·Frontiers in Marine Science ·Chao Liu, Zhang Lin, (unknown), Yanna Tang, Mao Wang, Wenqing Wang	0
2	A novel C1q domain-containing protein from Tridacna crocea exhibits dual functionality in symbiont recognition and immune defense 2025 ·Fish & Shellfish Immunology ·(unknown), Yanna Tang, Md. Abu Kawsar, Ke Huang, Xiaoyang Jin, Ziniu Yu, Fan Mao, Yang Zhang	0
3	Effects of hypo-osmotic stress on osmoregulation, antioxidant response, and energy metabolism in sea cucumber Holothuria moebii under desalination environment 2024 ·Environmental Research ·(unknown), Yanna Tang, (unknown), Cong Zhou, Zonghe Yu	9
4	Epinephelus coioides PCSK9 affect the infection of SGIV by regulating the innate immune response 2022 ·Fish & Shellfish Immunology ·(unknown), (unknown), Xiaoai Wang, (unknown), (unknown), Yanna Tang, (unknown), Xinyue Yang, Jiayang He, Hao Luo, Tong Zhang, Hong Qi, Xiao Chen, Qiwei Qin, Hongyan Sun	3
5	Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation breakdown → 2015 ·Journal of Thoracic Oncology ·Nan Chen, Wenfeng Fang, Jianhua Zhan, Shaodong Hong, Yanna Tang, Shiyang Kang, Yaxiong Zhang, Xiaobo He, Ting Zhou, Tao Qin, Yan Huang, Xianping Yi, Li Zhang	534
6	Erythropoietin Inhibits the Increase of Pulmonary Labile Zinc and the Expression of Inflammatory Mediators Following Subarachnoid Hemorrhage in Rats 2015 ·Neurocritical Care ·Yiting Zhou, Xudong Zhao, Yanna Tang, Lin Zhu, (unknown), Xiaojie Lu	2
7	The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis 2015 ·Medical Oncology ·(unknown), Wenfeng Fang, Yue Yan, Mengyao Wang, Shiyang Kang, Sheng Jin, Jianhua Zhan, Nan Chen, Shaodong Hong, Yunpeng Yang, Yuxiang Ma, Dacheng He, Tao Qin, Ting Zhou, Yanna Tang, Xiaobo He, Wenhua Liang, Li Zhang	12
8	Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer 2015 ·Oncotarget ·(unknown), Wenfeng Fang, Libing Mu, Yanna Tang, Lei Gao, Shengxiang Ren, Dengfeng Cao, Lixin Zhou, Aiqun Zhang, Deruo Liu, Caicun Zhou, Kwok‐Kin Wong, Lei Yu, Li Zhang, Liang Chen	39
9	The difference of clinical characteristics between patients with exon 19 deletion and those with L858R mutation in non-small cell lung cancer. 2015 ·Journal of Clinical Oncology ·Yaxiong Zhang, Dacheng He, Shiyang Kang, Wenfeng Fang, Shaodong Hong, Sheng Jin, Yanna Tang, Li Zhang	1
10	The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs 2015 ·Oncotarget ·Yanna Tang, Wenfeng Fang, Yaxiong Zhang, Shaodong Hong, Shiyang Kang, Yue Yan, Nan Chen, Jianhua Zhan, Xiaobo He, Tao Qin, Ge Li, Wenyi Tang, Peijian Peng, Li Zhang	202
11	PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival 2015 ·Oncotarget ·Wenfeng Fang, Shaodong Hong, Nan Chen, Xiaobo He, Jianhua Zhan, Tao Qin, Ting Zhou, Zhihuang Hu, Yuxiang Ma, Yuanyuan Zhao, Ying Tian, Yunpeng Yang, Cong Xue, Yanna Tang, Yan Huang, Hongyun Zhao, Li Zhang	61
12	The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients 2014 ·Tumor Biology ·Shaodong Hong, Ting Zhou, Wenfeng Fang, Cong Xue, Zhihuang Hu, Tao Qin, Yanna Tang, Yue Chen, Yuxiang Ma, Yunpeng Yang, Xue Hou, Yan Huang, Hongyun Zhao, Yuanyuan Zhao, Li Zhang	104
13	A Large-scale Cross-sectional Study of ALK Rearrangements and EGFR Mutations in Non-small-cell Lung Cancer in Chinese Han Population 2014 ·Scientific Reports ·Shaodong Hong, Wenfeng Fang, Zhihuang Hu, Ting Zhou, Yue Yan, Tao Qin, Yanna Tang, Yuxiang Ma, Yuanyuan Zhao, Cong Xue, Yan Huang, Hongyun Zhao, Li Zhang	25
14	Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis 2014 ·Drug Design Development and Therapy ·Peijian Peng, Hua Cheng, (unknown), Linjuan Zeng, Xuan Wu, Yumeng Liu, Lin Zhong, Yanna Tang, Siyang Wang, Hongyu Zhang, Zhibin Chen	12
15	Impact of Smoking Status on EGFR-TKI Efficacy for Advanced Non–Small-Cell Lung Cancer in EGFR Mutants: A Meta-analysis 2014 ·Clinical Lung Cancer ·(unknown), Shiyang Kang, Wenfeng Fang, Shaodong Hong, Wenhua Liang, Yue Yan, Tao Qin, Yanna Tang, Sheng Jin, Li Zhang	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact